Total Funding
65
53
Total FundingSeries D raised
Growth Score 65 in past quarter
-12 pts
Heat Score 53 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
74940
Phraxis is a medical device company developing solutions for patients who need vascular access to enable hemodialysis.
Michael J. Kallok: President and CEOPast Role: Cardiovascular Systems, President and CEO- John Seaberg: Founder and ChairmanPast Role: NeoChord, Co-Founder, CEO, Chairman
About the Company
Phraxis is a medical device company, develops treatment solutions for patients who need vascular access to enable hemodialysis. The company offers InterGraft, a percutaneously delivered arterio-venous shunt that provides a non-surgical approach for patients who need vascular access. It also develops devices for interventional nephrology to enable
physicians to manage their dialysis patients. The company was incorporated in 2008 and is based in St. Paul, Minnesota.
